Table 1 Baseline characteristics stratified by SUA level
Characteristicsan | All | SUA, mg/dLb | ||
|---|---|---|---|---|
2 to < 5 (n = 4607) | 5 to < 7 (n = 6990) | ≥ 7 (n = 2408) | ||
Age, yr | 69.8 (0.1) | 69.5 (0.1) | 69.8 (0.1) | 70.7 (0.2) |
Female, n (%) | 7181 (51.3) | 3200 (74.9) | 3153 (48.9) | 828 (37.5) |
Race, n (%) | ||||
White | 7278 (52) | 2354 (79.9) | 3690 (80.3) | 1234 (77.8) |
Black | 2537 (18.1) | 628 ( 5.9) | 1268 ( 7.7) | 641 (11.6) |
Mexican American | 2203 (15.7) | 895 (4.9) | 1046 (3.7) | 262 (3.0) |
Other | 1987 (14.2) | 730 (9.3) | 986 (8.3) | 271 (7.6) |
Education, n (%) | ||||
Low than high school | 4750 (33.9) | 1608 (20.8) | 2316 (21.0) | 826 (24.6) |
High school | 3315 (23.7) | 1061 (25.9) | 1679 (26.4) | 575 (25.4) |
College | 5940 (42.4) | 1938 (53.4) | 2995 (52.5) | 1007 (50.0) |
Smoke, n (%) | ||||
Never | 6869 (49.1) | 2553 (54.3) | 3331 (48.4) | 985 (40.4) |
Former | 5343 (38.2) | 1441 (33) | 2749 (39.7) | 1153 (50.3) |
Current | 1793 (13) | 613 (12.8) | 910 (11.9) | 270 ( 9.4) |
BMI, kg/m2 | ||||
< 25 | 3747 (26.8) | 1705 (39.8) | 1665 (22.1) | 377 (14.9) |
25 to < 30 | 5318 (38) | 1739 (36.2) | 2688 (38.8) | 891 (35.8) |
≥ 30 | 4940 (35.3) | 1163 (24) | 2637 (39.0) | 1140 (49.3) |
WBC, cells × 109/L | 7.07 (0.0) | 6.86 (0.1) | 7.09 (0.1) | 7.46 (0.1) |
Hemoglobin, g/dL | 14.10 (0.0) | 13.87 (0.0) | 14.24 (0.0) | 14.17 (0.1) |
Serum albumin, g/L | 41.99 (0.1) | 41.96 (0.1) | 42.08 (0.1) | 41.79 (0.1) |
TCHO, mmol/L | 5.15 (0.0) | 5.28 (0.0) | 5.12 (0.0) | 4.98 (0.0) |
TG, mmol/L | 1.73 (0.0) | 1.55 (0.0) | 1.76 (0.0) | 1.99 (0.0) |
UACR, mg/g | 48.68 (2.8) | 28.96 ( 2.3) | 42.42 ( 2.9) | 110.51 (13.2) |
eGFR, ml/min/1.73m2 | 73.68 (0.2) | 80.13 (0.3) | 72.94 (0.3) | 62.25 (0.5) |
ASCVD risk | 0.28 (0.0) | 0.30 (0.0) | 0.26 (0.0) | 0.27 (0.0) |
CCI, count | 1.65 (0.0) | 1.56 (0.0) | 1.61 (0.0) | 1.98 (0.1) |
Hypertension, n (%) | 9770 (69.8) | 2912 (58.9) | 4880 (67.4) | 1978 (81.3) |
Diabetes, n (%) | 4198 (30) | 1263 (21.4) | 2075 (24.8) | 860 (32.5) |
CV disease, n (%) | 3176 (22.7) | 819 (17.0) | 1579 (21.8) | 778 (32.3) |
Anti-hypertension, n (%) | 7164 (51.2) | 1893 (40.3) | 3560 (50.1) | 1711 (70.7) |
Lipid-lowering drugs, n (%) | 5274 (37.7) | 1594 (36) | 2684 (41) | 996 (44.0) |
Hypoglycemic, n (%) | 2741 (19.6) | 846 (14.0) | 1335 (15.8) | 560 (21.9) |
Urate-lowing agents, n (%) | 170 (1.2) | 50 (1.2) | 85 (1.1) | 35 (1.3) |